annual cash & cash equivalents:
$104.20M-$88.62M(-45.96%)Summary
- As of today (June 22, 2025), EVH annual cash & cash equivalents is $104.20 million, with the most recent change of -$88.62 million (-45.96%) on December 31, 2024.
- During the last 3 years, EVH annual cash & cash equivalents has fallen by -$162.08 million (-60.87%).
- EVH annual cash & cash equivalents is now -67.33% below its all-time high of $319.00 million, reached on December 31, 2020.
Performance
EVH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$246.55M+$142.34M(+136.60%)Summary
- As of today (June 22, 2025), EVH quarterly cash & cash equivalents is $246.55 million, with the most recent change of +$142.34 million (+136.60%) on March 31, 2025.
- Over the past year, EVH quarterly cash & cash equivalents has increased by +$81.40 million (+49.29%).
- EVH quarterly cash & cash equivalents is now -33.46% below its all-time high of $370.51 million, reached on September 30, 2020.
Performance
EVH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EVH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | +49.3% |
| 3 y3 years | -60.9% | +17.3% |
| 5 y5 years | +3.2% | +262.9% |
EVH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.9% | at low | at high | +155.3% |
| 5 y | 5-year | -67.3% | +3.2% | -33.5% | +262.9% |
| alltime | all time | -67.3% | >+9999.0% | -33.5% | >+9999.0% |
EVH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $246.55M(+136.6%) |
| Dec 2024 | $104.20M(-46.0%) | $104.20M(+7.9%) |
| Sep 2024 | - | $96.58M(-4.6%) |
| Jun 2024 | - | $101.25M(-38.7%) |
| Mar 2024 | - | $165.15M(-14.4%) |
| Dec 2023 | $192.82M(+2.5%) | $192.82M(+4.5%) |
| Sep 2023 | - | $184.54M(+29.5%) |
| Jun 2023 | - | $142.53M(-9.5%) |
| Mar 2023 | - | $157.52M(-16.3%) |
| Dec 2022 | $188.20M(-29.3%) | $188.20M(+20.1%) |
| Sep 2022 | - | $156.76M(-18.8%) |
| Jun 2022 | - | $193.07M(-8.1%) |
| Mar 2022 | - | $210.16M(-21.1%) |
| Dec 2021 | $266.28M(-16.5%) | $266.28M(+5.5%) |
| Sep 2021 | - | $252.50M(+21.8%) |
| Jun 2021 | - | $207.27M(-12.2%) |
| Mar 2021 | - | $236.03M(-26.0%) |
| Dec 2020 | $319.00M(+215.8%) | $319.00M(-13.9%) |
| Sep 2020 | - | $370.51M(+277.0%) |
| Jun 2020 | - | $98.27M(+44.6%) |
| Mar 2020 | - | $67.94M(-32.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $101.01M(-55.8%) | $101.01M(+4.4%) |
| Sep 2019 | - | $96.73M(+4.2%) |
| Jun 2019 | - | $92.82M(-45.7%) |
| Mar 2019 | - | $170.82M(-25.2%) |
| Dec 2018 | $228.32M(-4.2%) | $228.32M(+2.9%) |
| Sep 2018 | - | $221.84M(+12.0%) |
| Jun 2018 | - | $197.98M(-1.2%) |
| Mar 2018 | - | $200.32M(-16.0%) |
| Dec 2017 | $238.43M(+77.2%) | $238.43M(-17.0%) |
| Sep 2017 | - | $287.14M(+187.2%) |
| Jun 2017 | - | $99.97M(-4.1%) |
| Mar 2017 | - | $104.30M(-22.5%) |
| Dec 2016 | $134.56M(-7.7%) | $134.56M(+22.6%) |
| Sep 2016 | - | $109.78M(+4.4%) |
| Jun 2016 | - | $105.14M(-5.5%) |
| Mar 2016 | - | $111.29M(-23.6%) |
| Dec 2015 | $145.73M(>+9900.0%) | $145.73M(-30.0%) |
| Sep 2015 | - | $208.16M(-5.1%) |
| Jun 2015 | - | $219.37M(+1642.3%) |
| Mar 2015 | - | $12.59M(>+9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00 |
| Dec 2013 | $67.89M | - |
FAQ
- What is Evolent Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Evolent Health?
- What is Evolent Health annual cash & cash equivalents year-on-year change?
- What is Evolent Health quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Evolent Health?
- What is Evolent Health quarterly cash & cash equivalents year-on-year change?
What is Evolent Health annual cash & cash equivalents?
The current annual cash & cash equivalents of EVH is $104.20M
What is the all time high annual cash & cash equivalents for Evolent Health?
Evolent Health all-time high annual cash & cash equivalents is $319.00M
What is Evolent Health annual cash & cash equivalents year-on-year change?
Over the past year, EVH annual cash & cash equivalents has changed by -$88.62M (-45.96%)
What is Evolent Health quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EVH is $246.55M
What is the all time high quarterly cash & cash equivalents for Evolent Health?
Evolent Health all-time high quarterly cash & cash equivalents is $370.51M
What is Evolent Health quarterly cash & cash equivalents year-on-year change?
Over the past year, EVH quarterly cash & cash equivalents has changed by +$81.40M (+49.29%)